The global thyroid gland disorder treatment market is currently valued at more than USD 2,072 and is expected to reach around USD 2,358 billion by 2021, says Technavio.
Technavio has announced its latest market research report on the global thyroid gland disorder treatment market, under its cardiovascular and metabolic disorders portfolio. This market analysis discusses the major drivers and key emerging trends and offers an analysis of key vendors like Toppan Printing Mitsubishi Plastic, Amcor, Bemis, and Berry Plastics.
According to Barath Palada, a lead analyst for cardiovascular and metabolic disorders research at Technavio, “The number of countries whose population have excessive iodine intake increased at a CAGR of approximately 9% between 2007 and 2015, leading to iodine-induced hyperthyroidism and autoimmune thyroid disease. The data estimates suggest that in 2016 the households which had access to iodized salt globally ranged between 62-65%.”
Iodine deficiency occurs in the population living in areas where the soil has a low iodine content. This results in past glaciation or the repeated leaching effects of snow, water, and heavy rainfall. As a result, crops grown in these regions do not contain adequate amounts of iodine, which translates into iodine deficiency when consumed by a human.
Rising focus on emerging economies
Several vendors in the global thyroid gland disorder treatment market are are focusing on the untapped emerging economies such as the Middle East, Africa, China, and India. According to research studies, it is estimated that 42 million people in India suffer from thyroid diseases. For instance, companies such as AbbVie and Merck Sharp & Dohme collaborated with ITS to increase the awareness about thyroid gland disorders among individuals.
Increased outsourcing of non-core activities
Different aspects of research, such as product characterization testing and toxicology testing, are outsourced to third-party research organizations. Similarly, some vendors outsource the active pharmaceutical ingredient manufacturing or the entire manufacturing process to contract manufacturing organizations (CROs). This helps reduce operational costs, as most companies do not have to maintain expensive R&D laboratories and scientists.
This research report includes an in-depth analysis and market shares and sizes of the sub-segments and geography. An analysis of the key companies, including their market shares, business overview, key financials, etc. is provided in this study. This market study also provides a detailed analysis of key drivers, challenges, and opportunities influencing this market.
A more detailed analysis is available in the Technavio report titled, ‘Global Thyroid Gland Disorder Treatment Market 2017-2021’.
Other related reports:
- Global Endocrinology Drugs Market 2016-2020
- Global Pharmerging Markets 2017-2021
- Global Central Nervous System Disorders Therapeutics Market 2016-2020
To read more press releases – click here
